CEFAZOLIN SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for cefazolin sodium and what is the scope of patent protection?
Cefazolin sodium
is the generic ingredient in eight branded drugs marketed by Glaxosmithkline, Baxter Hlthcare, B Braun, Abraxis Pharm, Acs Dobfar, Aurobindo Pharma, Bedford, Cephazone Pharma, Dr Reddys, Facta Farma, Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Hospira, Hospira Inc, Qilu, Samson Medcl, Sandoz, Steri Pharma, Teva Pharms, Lilly, Hq Spclt Pharma, and Baxter Hlthcare Corp, and is included in forty-one NDAs. Additional information is available in the individual branded drug profile pages.There are eighteen drug master file entries for cefazolin sodium. Twenty suppliers are listed for this compound.
Summary for CEFAZOLIN SODIUM
US Patents: | 0 |
Tradenames: | 8 |
Applicants: | 23 |
NDAs: | 41 |
Drug Master File Entries: | 18 |
Finished Product Suppliers / Packagers: | 20 |
Raw Ingredient (Bulk) Api Vendors: | 64 |
Clinical Trials: | 8 |
Patent Applications: | 4,596 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in CEFAZOLIN SODIUM? | CEFAZOLIN SODIUM excipients list |
DailyMed Link: | CEFAZOLIN SODIUM at DailyMed |
Recent Clinical Trials for CEFAZOLIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, Riverside | Phase 2/Phase 3 |
HK Surgical, Inc. | Phase 2/Phase 3 |
University of British Columbia | Early Phase 1 |
Pharmacology for CEFAZOLIN SODIUM
Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for CEFAZOLIN SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for CEFAZOLIN SODIUM
US Patents and Regulatory Information for CEFAZOLIN SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma Farmaceutica | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065143-001 | Oct 18, 2004 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva Pharms | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 063018-001 | Mar 5, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Acs Dobfar | KEFZOL | cefazolin sodium | INJECTABLE;INJECTION | 061773-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cephazone Pharma | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065280-001 | Mar 18, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Acs Dobfar | KEFZOL | cefazolin sodium | INJECTABLE;INJECTION | 061773-005 | Sep 8, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Acs Dobfar | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065303-001 | Oct 22, 2008 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.